CPT code 17260 documents the destruction of a malignant skin lesion on the trunk, arms, or legs when the lesion is 0.5 cm or less in diameter. This code captures a common, low-complexity dermatologic procedure used to treat small cutaneous malignancies in outpatient settings. Nationally, accurate use of this code matters for clinical documentation, facility and professional billing, and monitoring utilization of minor dermatologic interventions for skin cancer management.

Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for use of 17260, the typical sites of service where the procedure is performed, and the categories of documentation and coding considerations that affect claim submission and coverage review. The publication also outlines benchmarking topics and policy updates relevant to minor skin lesion destruction, along with payer-specific coverage patterns and common administrative issues to watch.

This summary provides clinicians, coding professionals, and policy analysts with a practical reference to understand when to select CPT code 17260, what clinical scenario it represents, and which national payers commonly adjudicate claims for this service. Data not available in the input is noted where applicable.